Vakula Connect is our regular update for consultants deciding where to take their next assignment and for clients planning their next programme. This edition covers Q4 2022.
Market signals
- The year closed with the Food and Drug Omnibus Reform Act, adding diversity action plan requirements for pivotal trials and pushing sponsors to think about site selection differently.
- Year-end budget cycles brought a wave of contract extensions and a smaller number of new requisitions, a normal seasonal pattern.
- Layoffs in technology companies increased the supply of IT candidates, but few had regulated-environment experience, so GxP IT roles stayed hard to fill.
Roles in demand this quarter
Titles that recurred in client requisitions: Clinical Project Manager, Biostatistician, SAS Programmer, Network Engineer. Current openings are always on our careers page.
Signal to leaders
The disciplines that were hardest to fill were the ones where clients needed judgement as well as capacity; briefing for the judgement shortened time-to-fill.
At Vakula
We closed our first full year with a consultant network across nine pharma and five IT disciplines and clients in pharma, biotech and medical devices. The priority for 2023: depth in biostatistics and data management, where demand was growing fastest.
For consultants
Rate, duration, location and client are disclosed before you decide to interview; you get feedback after every submission; there are no fees to candidates at any stage. Send your resume.
For clients
Send one requisition and judge the shortlist. Start here.
Join the conversation
Tell us what you are working through at info@vakulatech.com; we may feature the question in a future edition.